SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-008228
Filing Date
2020-09-08
Accepted
2020-09-08 17:20:42
Documents
13
Period of Report
2020-09-03
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_090320.htm   iXBRL 8-K 36459
2 CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION ex3-1.htm EX-3.1 5802
  Complete submission text file 0001387131-20-008228.txt   223002

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20200903.xsd EX-101.SCH 3225
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20200903_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20200903_pre.xml EX-101.PRE 22736
6 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_090320_htm.xml XML 4022
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 201164897
SIC: 2834 Pharmaceutical Preparations